Management of obesity cardiomyopathy

References

• NIH Consensus Development Conference. Clinical guidelines on the identification, evaluation of and treatment of overweight and obesity in adults – the evidence report. Obes. Res. 6(Suppl. 2), 551–209 (1998).
   Google Scholar
• Alexander JK. Appendix. In: The Heart and Lung in Obesity. Alpert MA, Alexander JK (Eds). Futura Publishing, NY, USA, 239–243 (1998).
   Google Scholar
• Alpert MA. Obesity cardiomyopathy: pathophysiology and evaluation of the clinical syndrome. Am. J. Med. Sci. 321, 225–236 (2001).
   PubMed Web of Science ®Google Scholar
• Poirier P, Alpert MA. The heart. In: Obesity: Basis for Clinical Evaluation and Treatment. Eckel RH (Ed.). William and Wilkins, PA, USA, 187–201 (2003).
   Google Scholar
• Alexander JK. The cardiomyopathy of obesity. Prog. Cardiovasc. Dis. 27, 325–334 (1985).
   PubMed Web of Science ®Google Scholar
• Alexander JK, Alpert MA. Hemodynamic alterations with obesity in man. In: The Heart and Lung in Obesity. Alpert MA, Alexander JK (Eds). Futura Publishing, NY, USA, 45–56 (1998).
   Google Scholar
• Alpert MA, Alexander JK. Cardiac morphology and obesity in man. In: The Heart and Lung in Obesity. Alpert MA, Alexander JK (Eds). Futura Publishing, NY, USA, 25–44 (1998).
   Google Scholar
• Chakko S, Alpert MA, Alexander JK. Obesity and ventricular function in man: diastolic function. In: The Heart and Lung in Obesity. Alpert MA, Alexander JK (Eds). Futura Publishing, NY, USA, 57–76 (1998).
   Google Scholar
• Alpert MA, Alexander JK. Obesity and ventricular function in man: systolic function. In: The Heart and Lung in Obesity. Alpert MA, Alexander JK (Eds). Futura Publishing, NY, USA, 77–94 (1998).
   Google Scholar
• Alpert MA, Lambert CR, Panayiotou H et al. Relation of duration of morbid obesity of left-ventricular mass, systolic function and diastolic filling and effect of weight loss. Am. J. Cardiol. 76, 1194–1197 (1995).
   PubMed Web of Science ®Google Scholar
• Peterson LR, Waggoner AD, Schectman KB, Myer Gropler RJ, Barzulai B, Davila-Roman G. Alterations in left-ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J. Am. Coll. Cardiol. 43, 1399–1404 (2004).
   PubMed Web of Science ®Google Scholar
• Wong CY, O’Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations in left-ventricular myocardial characteristics associated with obesity. Circulation 110, 3081–3087 (2004).
   PubMed Web of Science ®Google Scholar
• Willens HJ, Chakko SC, Lowery MH et al. Tissue Doppler imaging of the right and left-ventricular in severe obesity (body mass index >35 kg/m2). Am. J. Cardiol. 94, 1087–1090 (2005).
   Web of Science ®Google Scholar
• Unger RH. Lipotoxic diseases. Ann. Rev. Med. 53, 319–336 (2002).
   PubMed Web of Science ®Google Scholar
• Labaan JP. Sleep apnea syndrome and obesity. Rev. Pneumonol. Clin. 58, 91–98 (2002).
   PubMedGoogle Scholar
• Koenig SM. Pulmonary complications of obesity. Am. J. Med. Sci. 321, 249–279 (2001).
   PubMed Web of Science ®Google Scholar
• Sugarman HJ, Fairman RP, Good RK, Engle K, Wolfe L, Kellum JM. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am. J. Clin. Nutr. 55(Suppl. 2), S597–S601 (1992).
   Google Scholar
• Alexander JK, Alpert MA. Pathogenesis and clinical manifestations of obesity cardiomyopathy. In: The Heart and Lung in Obesity. Alpert MA, Alexander JK (Eds). Futura Publishing, NY, USA, 133–146 (1998).
   Google Scholar
• Wang TJ, Parise H, Levy D et al. Obesity and the risk of new onset atrial fibrillation. J. Am. Med. Assoc. 292, 2471–2477 (2004).
   PubMed Web of Science ®Google Scholar
• Messerli FH, Sundgaard-Riise K, Reisin E, Dreslinski G, Dunn FG, Frohlich E. Disparate cardiovascular effects of obesity and arterial hypertension. Am. J. Med. 74, 808–812 (1983).
   PubMed Web of Science ®Google Scholar
• Messerli FH, Christie B, DeCarvalho JGR et al. Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion and plasma rennin activity. Arch. Intern. Med. 141, 81–85 (1981).
   PubMed Web of Science ®Google Scholar
• Messerli FH, Sungaard-Riise ED, Reisin ED et al. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann. Intern. Med. 94, 757–761 (1983).
   Google Scholar
• Alpert MA. Management of obesity cardiomyopathy. Am. J. Med. Sci. 321, 237–241 (2001).
   PubMed Web of Science ®Google Scholar
• Thakur V, Richards R, Reisen E. Obesity hypertension and the heart. Am. J. Med. Sci. 21, 242–248 (2001).
   Google Scholar
• Backman L, Freyschuss U, Hallberg D, Melcher A. Reversibility of cardiovascular changes in extreme obesity. Effects of weight reduction through jejunoileostomy. Acta Med. Scand. 205, 367–373 (1979).
   PubMedGoogle Scholar
• Alaud-din A, Meterissian S, Lisbona R, MacLean LD, Forse RA. Assessment of cardiac function in patients who are morbidly obese. Surgery 108, 809–820 (1990).
   PubMed Web of Science ®Google Scholar
• Alexander JK, Peterson KL. Cardiovascular effects of weight reduction. Circulation 45, 310–318 (1972).
   PubMed Web of Science ®Google Scholar
• Reisen E, Frohlich ED, Messerli FH et al. Cardiovascular changes after weight reduction in obesity hypertension. Ann. Intern. Med. 98, 315–319 (1983).
   PubMed Web of Science ®Google Scholar
• Alpert MA, Terry BE, Kelly DL. Effect of weight loss on cardiac chamber size, wall thickness and left-ventricular function in morbid obesity. Am. J. Cardiol. 55, 783–786 (1985).
   PubMed Web of Science ®Google Scholar
• Alpert MA, Lambet CR, Terry BE et al. Effect of weight loss on left-ventricular mass in nonhypertensive morbidly obese patients. Am. J. Cardiol. 73, 918–921 (1994).
   PubMed Web of Science ®Google Scholar
• MacMahon SW, Wilcken DEL, MacDonald GJ. The effect of weight reduction on left-ventricular mass. A randomized, controlled trial in young, overweight, hypertensive patients. N. Engl. J. Med. 314, 334–339 (1985).
   Web of Science ®Google Scholar
• Karason K, Wallentin I, Larsson B, Sjostrom L. Effects of obesity and weight loss on left-ventricular mass and relative wall thickness: survey and intervention study. British Med. J. 315, 912–916 (1997).
   PubMed Web of Science ®Google Scholar
• Wirth A, Kröger H. Improvement of left-ventricular morphology and function in obese subjects following a diet and exercise program. Int. J. Obes. Relat. Metab. Disord. 19, 61–66 (1995).
   PubMed Web of Science ®Google Scholar
• Jordan J, Messerli FH, Lavie CJ, Aepfelbacher FC, Soria F. Reduction of weight and left-ventricular mass with serotonin uptake inhibition of obese patients with systemic hypertension. Am. J. Cardiol. 75, 743–747 (1995).
   PubMed Web of Science ®Google Scholar
• Himeno E, Nishino K, Nakashima Y, Kuroiwa A, Ikeda M. Weight reduction regresses left-ventricular mass regardless of blood pressure level in obese subjects. Am. Heart J. 131, 313–319 (1996).
   PubMed Web of Science ®Google Scholar
• Alpert MA, Lambert CR, Terry BE et al. Effect of weight loss on left-ventricular diastolic filling in morbid obesity. Am. J. Cardiol. 76, 1198–1201 (1995).
   PubMed Web of Science ®Google Scholar
• Karason K, Wallentin I, Larrson B, Sjostrom L. Effects of obesity and weight loss on cardiac function and valvular performance. Obes. Res. 6, 422–429 (1998).
   PubMedGoogle Scholar
• DasGupta P, Ramhamdany E, Bridgen G, Lahiri A, Baird IM, Raftery EB. Improvement of left-ventricular function after rapid weight loss in obesity. Eur. Heart J. 13, 1060–1066 (1992).
   PubMed Web of Science ®Google Scholar
• Reid CM, Dart AM, Dewas EM, Jennings EL. Interactions between the effects of exercise and weight loss on risk factors, cardiovascular hemodynamics and left-ventricular structure in overweight subjects. J. Hypertension 12, 291–301 (1994).
   PubMed Web of Science ®Google Scholar
• Alpert MA, Terry BE, Lambert CR et al. Factors influencing left-ventricular systolic function in nonhypertensive morbidly obese patients, and effect of weight loss induced by gastroplasty. Am. J. Cardiol. 71, 733–737 (1993).
   PubMed Web of Science ®Google Scholar
• Messerli FH. Cardiopathy of obesity. A not-so-Victorian disease. N. Engl. J. Med. 314, 378–380 (1986).
   PubMed Web of Science ®Google Scholar
• Estes EH, Sieker HO, McIntosh HD, Kelser GA. Reversible cardiopulmonary syndrome with extreme obesity. Circulation 41, 179–187 (1957).
   Google Scholar
• Alpert MA, Terry BE, Mulekar M et al. Cardiac morphology and left-ventricular function in morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am. J. Cardiol. 80, 736–740 (1997).
   PubMed Web of Science ®Google Scholar
• Kenchaiah S, Evans JC, Levy D et al. Obesity and the risk of heart failure. N. Engl. J. Med. 347, 305–313 (2002).
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh R, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic congestive heart failure. J. Am. Coll. Cardiol. 43, 1439–1444 (2004).
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Milani RV. Obesity and cardiovascular disease. J. Am. Coll. Cardiol. 42, 677–679 (2003).
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Mehra MR, Milani RV. Obesity and heart failure progrnosis: paradox or reverse epidemiology? Eur. Heart J. 26, 5–7 (2005).
   PubMed Web of Science ®Google Scholar
• Horwich TB, Fonarwo GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J. Am. Coll. Cardiol. 38, 789–795 (2001).
   PubMed Web of Science ®Google Scholar